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Abstract
People living in endemic areas often habour several malaria infections at once. High-resolution genotyping can distinguish
between infections by detecting the presence of different alleles at a polymorphic locus. However the number of infections
may not be accurately counted since parasites from multiple infections may carry the same allele. We use simulation to
determine the circumstances under which the number of observed genotypes are likely to be substantially less than the
number of infections present and investigate the performance of two methods for estimating the numbers of infections
from high-resolution genotyping data. The simulations suggest that the problem is not substantial in most datasets: the
disparity between the mean numbers of infections and of observed genotypes was small when there was 20 or more alleles,
20 or more blood samples, a mean number of infections of 6 or less and where the frequency of the most common allele
was no greater than 20%. The issue of multiple infections carrying the same allele is unlikely to be a major component of the
errors in PCR-based genotyping. Simulations also showed that, with heterogeneity in allele frequencies, the observed
frequencies are not a good approximation of the true allele frequencies. The first method that we proposed to estimate the
numbers of infections assumes that they are a good approximation and hence did poorly in the presence of heterogeneity.
In contrast, the second method by Li et al estimates both the numbers of infections and the true allele frequencies
simultaneously and produced accurate estimates of the mean number of infections.
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Introduction
People who live in malaria-endemic areas may have several
concurrent infections. Accurately discriminating between these
both yields the multiplicity of infection (MOI), an epidemiological
measure of the number of infections per individual, and can
improve the understanding of many areas of malariology, such as
the dynamics of infections, pathogenesis, effect of transmission
intensity, drug efficacy and parasite genetics.
Plasmodium populations are highly diverse. Polymerase chain
reaction (PCR)-based genotyping using polymorphic loci has been
established to discriminate parasite clones within an individual.
Whilst PCR can detect the alleles of parasites present in a blood
sample, it does not always give an accurate count of the infections
present since parasites from multiple infections may bear the same
allele or alleles close in size. High-resolution techniques have
increased the discriminatory power by more precisely determining
the size or sequence of the alleles. However since the true number
of infections is unknown, the accuracy of high-resolution
techniques cannot be determined. Two questions arise: (i) Is there
substantial underestimation of the multiplicity in the blood
samples due to multiple indistinguishable genotypes? (ii) What is
the distribution of the number of infections in the population from
which the sample was drawn?
There have been few attempts to address these issues. Carter
and Mcgregor [1] derived a formula to estimate the mean number
of infections using data on a single locus which has two alleles. Hill
and Babiker [2] extended the equations to incorporate multiple
alleles and loci. However with the large number of alleles
distinguished using high-resolution genotyping, this method
becomes cumbersome to implement. Li and colleagues developed
models which have the principal aim of estimating either
haplotype frequencies [3] or haplotype-trait associations [4], but
can also allow the number of infections to be estimated.
There is a lack of information on the circumstances under
which the number of infections and number of observed genotypes
differ substantially. Factors such as the number of alleles, the
heterogeneity of allele frequencies, number of blood samples and
mean number of infections are likely to play a role.
In this paper, we (a) present simulations to evaluate the impact
of different factors on the disparity between the number of
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observed genotypes and the number of infections present and (b)
evaluate two methods of estimating the numbers of infections.
Methods
Due to the large number of alleles distinguished by high-
resolution genotyping, we focus on one marker gene. Adding
information from a second marker is not justified since in practice
it would not greatly enhance the ability to distinguish between
infections and would increase complexity.
Simulations to determine when the numbers of
infections and observed genotypes differ substantially
For each individual simulated blood sample, we randomly
generated the number of infections and then randomly selected an
allele for each infection. We then determined the numbers of
observed genotypes. The simulations only refer to the time that a
blood sample is taken, giving a cross-sectional snapshot of the
infections present in an individual. We do not simulate the
processes of acquiring and clearing infections.
We defined a baseline scenario with 100 blood samples, the
number of infections per blood sample following a zero-truncated
Poisson distribution with a mean of 5.03 infections corresponding
to m of 5, and 20 alleles of equal frequency. We investigated the
effect of the different factors by varying them one by one (Table 1).
A simulated sample of n blood samples will have stochasticity due
to the random generation of both the numbers of infections per
blood samples from a distribution and the alleles assigned to each
infection. We captured the variability in the mean number of
observed genotypes by simulating 101 sets for each scenario, each
set with n blood samples. The minimum and maximum mean
from the 101 sets are presented.
Methods to estimate the numbers of infections from
high-resolution genotyping data
We present two potential methods, one proposed here and one
previously described. They differ in their approach but, in
practice, the most important difference between them is that the
first estimates the numbers of infections assuming that the
observed allele frequencies are a good approximation of the true
allele frequencies, whereas the second is able to estimate numbers
of infections and true allele frequencies simultaneously. Thus we
investigate whether the added complexity of the second method is
necessary to provide accurate estimates.
Method 1: Estimating numbers of infections only. The
first model estimates the parameters of the distribution of the
numbers of infections. The observed allele frequencies are used to
derive the conditional probabilities of observing j genotypes given
that there are k infections present in a blood sample. These
conditional probabilities are then combined in a Bayesian model
with the frequencies of observed genotypes and an assumed
distribution for the numbers of infections. The details are provided
below. This model does not estimate the true allele frequencies but
assumes that the allele frequencies are either known from another
source or that the observed allele frequencies are a good
approximation of the true allele frequencies.
Details of Method 1. We are interested in the unknown
frequencies of k infections in the selected blood samples, ak, and in
the population from which they were drawn, a’k for k~1,::::M.
We choose the integer M to be greater than the maximum
number of observed genotypes with the intention that M is larger
than the unknown maximum number of infections per blood
sample.
The observed frequencies of blood samples with j genotypes, bj ,
follow a multinomial distribution (b1,:::bM )*Mn(Nc,p1,::::pM )
where Nc is the number of blood samples in a population survey
and pj is the probability of a blood sample having j observed
genotypes.
We derive pj using the conditional probabilities of observing j





We obtain pjDk from the observed allele frequencies using
simulation. This avoids the need to determine the equations,
which become complicated for large k. For each k, we randomly
select 100,000 samples of k alleles and count the frequencies of the
numbers of distinct genotypes. The true allele frequencies are
unknown, we assume that the observed allele frequencies are a
reasonable approximation and that the alleles are randomly
distributed.
We allow for sampling variation in the numbers of infections.
We specify that the frequencies of infections in the sample of blood
samples, ak, arise from a multinomial distribution
(a1,:::aM )*Mn(Nc,a’1,::::a’M ) where a’k are the population
frequencies we wish to estimate. We assume that a’k are specified
by the probability function of a chosen distribution and estimate
the values of the parameters describing this distribution to obtain
our estimates.
The model was fitted using the Metropolis-Hastings algorithm
in WinBUGS [5]. We used R to simulate the conditional
probabilities, pass the inputs to WinBUGS via R2Bugs [6] and
return the results.
Method 2: Estimating both numbers of infections and
allele frequencies simultaneously. The second method
Table 1. Factors investigated by the simulations.
parameter values*
number of alleles{ 2, 3, 4, 5, 7, 15, 20, 30, 50, 100
frequency of most common allele{ 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9
mean number of infections 1.13, 1.27, 1.58, 2.31, 3.16, 4.07, 5.03, 6.01, 7.01, 8.00, 9.00, 10.00, 11.00
distribution of numbers of blood samples zero-truncated Poisson, zero-truncated negative binomial
number of blood samples 5, 10, 15, 20, 30, 50, 100
*The baseline scenario is indicated by bold font.
{All alleles have equal frequency.
{The remaining alleles have equal frequency.
doi:10.1371/journal.pone.0042496.t001
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estimates both the distribution of the numbers of infections and the
true allele frequencies simultaneously using the Expectation-
Maximization algorithm [7]. The model is described by Li et al
[3] and is implemented in R [6] using the package malaria.em.
This model was originally aimed at estimating multi-loci haplotype
frequencies, a more complicated problem, but is readily used here
with data from only one marker gene. By iteratively alternating
between performing an expectation (E) step, which computes the
expectation of the log-likelihood evaluated using the current
estimate for the parameters, and a maximization (M) step, which
computes parameters maximizing the expected log-likelihood
found on the E step, the EM approach finds the maximum
likelihood estimates of the parameters. The numbers of infections
are assumed to follow a zero-truncated Poisson distribution.
To evaluate how well these methods perform in different
circumstances, we applied them to the simulations described
above. We also tested how well they performed when the
assumption of a Poisson distribution for the numbers of infections
is incorrect by applying them simulated numbers of observed
genotypes generated from negative binomial distributions with
different variances.
Example using genotyping data
We apply both methods to data from a study of malaria
infections in children in Maprik District, Papua New Guinea [8–
11]. Plasmodium falciparum and P. vivax are both present in this area.
Children aged one to three years at enrolment were followed up
over 16 months, but only blood samples from the baseline survey
were included in this analysis. There were 190 children enrolled in
March 2006, but only samples positive by microscopy or LDR, a
molecular method for Plasmodium species detection [12], were
genotyped using high-resolution capillary electrophoresis-based
PCR. The P falciparum infections were genotyped using one marker
(msp2) and the P vivax infections with two markers (msp1F3 and
MS16).
Ethics statement
The cohort study was approved by institutional review boards of
the PNG Medical Research Advisory Committee (approvals 05.19
and 09.24), University Hospitals Case Medical Center (Cleveland,
Ohio USA), and the Ethikkommission beider Basel (approval 03/
06). Informed written consent was provided by the parents or legal
guardians of each child.
Results
Simulations to determine when the numbers of
infections and observed numbers of genotypes differ
There was variation in the simulated mean numbers of observed
genotypes due to random variation in numbers of infections and in
the alleles selected (Figure 1, shaded polygons). The disparity
between the number of infections and number of observed
genotypes was greater with increasing mean numbers of infections
(Figure 1a), decreasing numbers of alleles (Figure 1b) and
increasing heterogeneity in allele frequencies (Figure 1c). Small
sample sizes lead to increased variability but there was no
substantial difference between the true number of infections and
the numbers of genotypes observed (Figure 1d). The disparity was
small where there were 20 or more alleles, 20 or more blood
samples, a mean MOI of 6 or less and where the frequency of the
most common allele was no greater than 20%.
Evaluation of methods to estimate the numbers of
infections
Both methods were applied to the simulated data above to
evaluate how well they could reproduce the mean number of
infections. The methods were applied to each of the 101 sets of n
simulated blood samples for each scenario and the distributions of
estimated means are shown as boxplots.
The estimates using Method 1 (Figure 2, left hand column) were
generally good where the observed allele frequencies would be a
reasonable approximation of the true allele frequencies. Where
there was heterogeneity in allele frequencies, however, they were
poor (Figure 2e). The observed allele frequencies are a poor
approximation of the true frequencies in the presence of
heterogeneity in the allele frequencies (Figure 3). This is because
the chance of multiple infections with the same allele occurring in
the same blood sample is greater the higher the allele frequency. If
the true allele frequencies were known, then Method 1 performed
well (results not shown).
The second method by Li et al (Figure 2, right hand column)
provided unbiased estimates even if there was heterogeneity in
allele frequencies. The variability of the estimates was large under
circumstances where there was very little information such as for a
very large degree of heterogeneity in allele frequencies, small
numbers of blood samples or very few alleles. Coverage of the 95%
confidence intervals was reasonably good for both methods (not
shown), ranging from 91% to 98%, when restricted to circum-
stances when the bias was low. However coverage fell dramatically
when there was substantial heterogeneity in allele frequencies with
Method 1.
The mean number of infections was reasonably accurately
estimated even when the assumption of a Poisson distribution for
the numbers of infections was incorrect, unless the extra-Poisson
variation was large (Figure 4). However, although we tested this
assumption using the negative binomial distribution, we did not
exhaustively test all possible distributions.
Application to data
Of the samples from 190 children aged 1 to 3 years in Maprik
district, Papua New Guinea, 76 (40%) were positive by microscopy
or LDR for P falciparum and 80 (42%) for P vivax. The number of
alleles observed ranged from 31 to 67 for the 3 markers (Table 2).
There was little difference between the mean number of observed
genotypes and estimated mean number of infections in this dataset
suggesting that there were few infections obscured by shared
alleles. Both methods estimated slightly a different mean MOI for
P vivax infections from the two markers. This is likely to be due to
the slightly lower detectibility of MS16 compared to msp1F3 [10].
Discussion
Our simulations indicate that the problem of indistinguishable
alleles is unlikely to lead to substantial underestimation of the
number of infections by using the number of observed genotypes.
The size of the disparity was small for 20 or more alleles, a sample
size of 20 or greater, a mean MOI of 6 or less and where the
frequency of the most common allele was no greater than 20%.
We did not, however, simulate combinations of these variables.
Since none of the baseline values we adopted (100 blood samples,
20 alleles of equal frequency, a zero-truncated Poisson distribution
with mean 5.03 infections) strongly impacted on the number of
observed genotypes, it seems unlikely that a more generous value
in one variable could compensate for poor value in another, such
as a marker with poor discriminatory ability in combination with a
larger number of blood samples. These approximate cut-offs could
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serve as criteria for selecting genetic markers for discriminating
between infections in an individual. They also support guidelines
for the related problem of distinguishing recrudescences from new
infections in clinical trials of drug efficacy [13] and justify the use
of statistical methods which assume that the observed MOI is
reasonably accurate [14].
Accurate estimates of the mean number of infections could be
obtained. Both methods investigated in this study differ from
previous studies [1,2] in that, facilitated by the large number of
alleles detected by high-resolution genotyping, they concentrate on
only one marker gene. Assumptions about the allele frequencies
were found to be important. The method by Li et al, which uses the
EM algorithm to estimate both the numbers of infections and the
true allele frequencies simultaneously, provided unbiased esti-
mates. In contrast, method 1 which assumes that the observed
allele frequencies are similar to the true allele frequencies had
biased estimates in some cases. This method would only be
appropriate where the observed allele frequencies are similar to
the true frequecies (such as for homogenous allele frequencies or
low MOI) or if they are known from another source. The observed
allele frequencies suffer from the same problem that multiple
infections bearing the same allele are not counted. This is also true
of prevalence, and the distinction between the prevalence and
frequency of alleles has been previously illustrated [15].
Neither method takes detectability into account. The blood
samples do not necessarily contain parasites from all the infections
present if there are low densities in the blood stream. This could be
due to a low parasite biomass, sequestration or synchronisation.
When the parasites are present at low levels in the sample, they
may not be detected due to methodological constraints with PCR
[16,17]. In multi-clonal infections, minority variants might be
missed due to being outcompeted in the competition for primers or
other consituents of the reaction mix [10]. There is variation in
assay sensitivity between different laboratories [18] and between
different markers. Reported estimates of the probability of
dectecting a clone lie in the range of 0.4 to 0.9 for P. falciparum
and P. vivax [10,11,19,20]. The model estimates refer only to
infections which would have been counted if they had been
distinguished in the genotyping.
We assume that the alleles are distributed at random. In the case
of markers associated with drug resistance, the distribution of
alleles is unlikely to be random [21] although these are unlikely to
be useful for estimating the MOI. The assumption would also be
untrue if there are multiple blood samples from the same hosts,
especially if they are taken within a short time period. Correlation
between alleles could also arise due to sibling infections which
could occur if gametocytes from multiple infections are taken up in
the same blood meal and, following meiosis, multiple related
sporozoites are injected into a person in one bite. Recent work has
suggested that there may be discrete spatial clusters of P falciparum
parasite types [22].
Figure 1. Impact of factors on the simulated mean number of genotypes. a: Mean number of infections b: number of alleles c: frequency of
most common allele d: number of blood samples. Solid line: mean number of infections, shaded polygon: minimum and maximum of mean observed
number of genotypes for the 101 simulated sets of n blood samples. Baseline case: 100 children, 20 alleles of equal frequency, the number of
infections per blood sample follows a zero-truncated Poisson distribution with a mean of 5.03 (Table 1). Each panel shows the effect of varying one
factor from the baseline case.
doi:10.1371/journal.pone.0042496.g001
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This problem is distinct from the adjustment of antimalarial
drug efficacy trial results using PCR data. In this case, interest
centres on whether a single infection detected following treatment
signifies a new infection or a treament failure. It has been
considered elsewhere [17,23–28].
Method 1 does not estimate the number of infections in an
individual blood sample, but rather only the distributions which
best approximate the population frequencies. Method 2, by Li et al,
can additionally give the posterior probabilities for different
configurations of marker genes and numbers of infections
corresponding to the observed genotypes for each individual.
Extensions could be made by including the option of a negative
binomial distribution for the number of infections in a host, and by
considering non-random selection of alleles. For the method we
had proposed (method 1), in theory it would also be possible to
estimate the allele frequencies in addition to the numbers of
infections. However, in practice, simulating the matrix of
conditional probabilities, pjDk, at each iteration would be very
time-consuming.
In conclusion, we have shown that with high-resolution
genotyping the problem of underestimating numbers of infections
due to multiple infections bearing the same allele is unlikely to be
substantial. Accurate estimates of the mean number of infections
can be obtained with the method by Li et al which can be
implemented in R using the package malaria.em. In most surveys
of malaria infection, far more than 20 blood samples will be typed
and the mean numbers of observed genotypes as detected by
typing size polymorphic markers have been reported to be lower
than 6 even in areas of intense transmission. Most markers
established for genotyping have exhibited more than 20 alleles
with frequencies usually below 20%. Under such circumstances,
the difference between the mean number of infections and
observed genotypes is likely to be small.
Figure 2. Model performance: estimated numbers of infections from the simulated sets of blood samples. LH column: Method 1, RH
column: Method 2. Solid line: true mean number of infections, shaded polygon: minimum and maximum of mean observed number of genotypes for
the 101 sets (samples of n blood samples) for each scenario. Boxplots: Estimates of the mean number of infections for each of the 101 sets. Baseline
scenario: 100 children, 20 alleles of equal frequency, the number of infections per blood sample follows a zero-truncated Poisson distribution and a
mean of 5.03 (Table 1).
doi:10.1371/journal.pone.0042496.g002
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Figure 3. Actual and observed frequency of the most common allele. Solid line: line of equality, shaded polygon: the minimum and
maximum observed frequencies of the most common allele for the 101 sets (each of 100 blood samples) for each scenario. There were 20 alleles, the
frequency of the most dominant allele is shown on the X-axis, the remaining 19 had equal frequency. The number of infections per blood sample
followed a zero-truncated Poisson distribution with a mean of 5.03.
doi:10.1371/journal.pone.0042496.g003
Figure 4. Model performance when the assumed distribution for the numbers of infections is incorrect. The observed numbers of
genotypes were simulated using numbers of infections following negative binomial distributions, however the models assume that the numbers of
infections follow a Poisson distribution. The parameter m was set to 3. A small value of r indicates larger variation and skew compared to a Poisson
distribution whereas a value of 100 is similar to a Poisson. LH: Method 1 RH: Method 2. Solid line: true mean number of infections, shaded polygon:
minimum and maximum of mean observed number of genotypes for the 101 sets (each set of n blood samples) for each scenario. Boxplots: Estimates
of the mean number of infections for each of the 101 sets. We simulated blood samples from 100 children and 20 alleles of equal frequency (Table 1).
doi:10.1371/journal.pone.0042496.g004
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